Temozolomide For Intravenous Infusion Injection
Item Name Code (INC) 68922
Additional Information for Temozolomide For Intravenous Infusion Injection
Temozolomide for Intravenous Infusion Injection is a medication that falls under the supply class of Drugs and Biologicals in the supply group of Medical, Dental, and Veterinary Equipment and Supplies.
Temozolomide is an anticancer medication that is used to treat certain types of brain tumors, specifically glioblastoma multiforme (GBM) and anaplastic astrocytoma. It is administered through intravenous infusion, meaning it is delivered directly into the bloodstream through a vein.
This medication works by interfering with the growth and spread of cancer cells in the body. It is typically used in combination with other treatments, such as radiation therapy, to improve the effectiveness of the overall treatment plan.
It is important to note that Temozolomide should only be used under the supervision of a healthcare professional, as it can have serious side effects and requires careful monitoring. Common side effects may include nausea, vomiting, fatigue, and low blood cell counts.
If you have any further questions or need more information, please let me know.
Related Item Names for INC 68922 Temozolomide For Intravenous Infusion Injection
NATO Stock Numbers with Item Name 68922 Temozolomide For Intravenous Infusion Injection Page 1 of 1
- 3400957475543
- RNCC: 3 | RNVC: 2 | DAC: 4